Humanistic counselling plus pastoral care as usual versus pastoral care as usual for the treatment of psychological distress in adolescents in UK state schools (ETHOS): a randomised controlled trial.


Journal

The Lancet. Child & adolescent health
ISSN: 2352-4650
Titre abrégé: Lancet Child Adolesc Health
Pays: England
ID NLM: 101712925

Informations de publication

Date de publication:
03 2021
Historique:
received: 19 08 2020
revised: 04 11 2020
accepted: 10 11 2020
pubmed: 24 1 2021
medline: 19 3 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

About one in seven adolescents have a mental health disorder in England, UK. School counselling is one of the most common means of trying to address such a problem. We aimed to determine the effectiveness and cost-effectiveness of school-based humanistic counselling (SBHC) for the treatment of psychological distress in young people in England, UK. We did a two-arm, individually randomised trial in 18 secondary state-funded schools across the Greater London area of the UK. Participants were randomly assigned (1:1) using a centrally secure randomisation procedure with random permuted blocks to either SBHC plus schools' pastoral care as usual (PCAU), or PCAU alone. Participants were pupils aged 13-16 years who had moderate-to-severe levels of emotional symptoms (measured by a score of ≥5 on the Strengths and Difficulties Questionnaire Emotional Symptoms scale) and were assessed as competent to consent to participate in the trial. Participants, providers, and assessors (who initially assessed and enrolled participants) were not masked but testers (who measured outcomes) were masked to treatment allocation. The primary outcome was psychological distress at 12 weeks (Young Person's Clinical Outcomes in Routine Evaluation measure [YP-CORE]; range 0-40), analysed on an intention-to-treat basis (with missing data imputed). Costs were assessed at 24 weeks (Client Service Receipt Inventory and service logs). The trial was registered with ISRCTN, number ISRCTN10460622. 329 participants were recruited between Sept 29, 2016, and Feb 8, 2018, with 167 (51%) randomly assigned to SBHC plus PCAU and 162 (49%) to PCAU. 315 (96%) of 329 participants provided data at 12 weeks and scores were imputed for 14 participants (4%). At baseline, the mean YP-CORE scores were 20·86 (SD 6·38) for the SBHC plus PCAU group and 20·98 (6·41) for the PCAU group. Mean YP-CORE scores at 12 weeks were 16·41 (SD 7·59) for the SBHC plus PCAU group and 18·34 (7·84) for the PCAU group (difference 1·87, 95% CI 0·37-3·36; p=0·015), with a small effect size (0·25, 0·03-0·47). Overall costs at 24 weeks were £995·20 (SD 769·86) per pupil for the SBHC plus PCAU group and £612·89 (1224·56) for the PCAU group (unadjusted difference £382·31, 95% CI £148·18-616·44; p=0·0015). The probability of SBHC being more cost-effective reached 80% at a willingness to pay of £390 for a 1-point improvement on the YP-CORE. Five serious adverse events occurred for four participants in the SBHC plus PCAU group, all involving suicidal intent. Two serious adverse events occurred for two participants in the PCAU group, one involving suicidal intent. The addition of SBHC to PCAU leads to small reductions in psychological distress, but at an additional economic cost. SBHC is a viable treatment option but there is a need for equally rigorous evaluation of alternative interventions. This work was supported by the Economic and Social Research Council (grant reference ES/M011933/1).

Sections du résumé

BACKGROUND
About one in seven adolescents have a mental health disorder in England, UK. School counselling is one of the most common means of trying to address such a problem. We aimed to determine the effectiveness and cost-effectiveness of school-based humanistic counselling (SBHC) for the treatment of psychological distress in young people in England, UK.
METHODS
We did a two-arm, individually randomised trial in 18 secondary state-funded schools across the Greater London area of the UK. Participants were randomly assigned (1:1) using a centrally secure randomisation procedure with random permuted blocks to either SBHC plus schools' pastoral care as usual (PCAU), or PCAU alone. Participants were pupils aged 13-16 years who had moderate-to-severe levels of emotional symptoms (measured by a score of ≥5 on the Strengths and Difficulties Questionnaire Emotional Symptoms scale) and were assessed as competent to consent to participate in the trial. Participants, providers, and assessors (who initially assessed and enrolled participants) were not masked but testers (who measured outcomes) were masked to treatment allocation. The primary outcome was psychological distress at 12 weeks (Young Person's Clinical Outcomes in Routine Evaluation measure [YP-CORE]; range 0-40), analysed on an intention-to-treat basis (with missing data imputed). Costs were assessed at 24 weeks (Client Service Receipt Inventory and service logs). The trial was registered with ISRCTN, number ISRCTN10460622.
FINDINGS
329 participants were recruited between Sept 29, 2016, and Feb 8, 2018, with 167 (51%) randomly assigned to SBHC plus PCAU and 162 (49%) to PCAU. 315 (96%) of 329 participants provided data at 12 weeks and scores were imputed for 14 participants (4%). At baseline, the mean YP-CORE scores were 20·86 (SD 6·38) for the SBHC plus PCAU group and 20·98 (6·41) for the PCAU group. Mean YP-CORE scores at 12 weeks were 16·41 (SD 7·59) for the SBHC plus PCAU group and 18·34 (7·84) for the PCAU group (difference 1·87, 95% CI 0·37-3·36; p=0·015), with a small effect size (0·25, 0·03-0·47). Overall costs at 24 weeks were £995·20 (SD 769·86) per pupil for the SBHC plus PCAU group and £612·89 (1224·56) for the PCAU group (unadjusted difference £382·31, 95% CI £148·18-616·44; p=0·0015). The probability of SBHC being more cost-effective reached 80% at a willingness to pay of £390 for a 1-point improvement on the YP-CORE. Five serious adverse events occurred for four participants in the SBHC plus PCAU group, all involving suicidal intent. Two serious adverse events occurred for two participants in the PCAU group, one involving suicidal intent.
INTERPRETATION
The addition of SBHC to PCAU leads to small reductions in psychological distress, but at an additional economic cost. SBHC is a viable treatment option but there is a need for equally rigorous evaluation of alternative interventions.
FUNDING
This work was supported by the Economic and Social Research Council (grant reference ES/M011933/1).

Identifiants

pubmed: 33484658
pii: S2352-4642(20)30363-1
doi: 10.1016/S2352-4642(20)30363-1
pmc: PMC9765869
pii:
doi:

Banques de données

ISRCTN
['ISRCTN10460622']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-189

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

Psychol Psychother. 2017 Jun;90(2):138-155
pubmed: 27470500
Arch Dis Child. 2021 Jul;106(7):698-704
pubmed: 33208398
Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S68-80
pubmed: 9566468
J Sch Psychol. 2016 Oct;58:73-89
pubmed: 27586071
J Child Psychol Psychiatry. 2013 Sep;54(9):977-85
pubmed: 23442096
J Pers Disord. 2006 Oct;20(5):510-23
pubmed: 17032162
Clin Psychol Rev. 2017 Feb;51:30-47
pubmed: 27821267
World Psychiatry. 2015 Jun;14(2):207-22
pubmed: 26043339
Sch Psychol Q. 2014 Jun;29(2):213-232
pubmed: 24933218
Child Adolesc Psychiatry Ment Health. 2010 Apr 22;4:12
pubmed: 20412578
Psychother Res. 2013;23(3):355-65
pubmed: 23046314
Trials. 2018 Mar 9;19(1):175
pubmed: 29523206
Am J Prev Med. 2016 Jul;51(1):114-26
pubmed: 27320215
Arch Pediatr Adolesc Med. 1998 Jan;152(1):25-33
pubmed: 9452704
Lancet Psychiatry. 2019 Dec;6(12):1011-1020
pubmed: 31734106
Health Econ. 1994 Sep-Oct;3(5):309-19
pubmed: 7827647
BMJ. 2013 Apr 24;346:f2304
pubmed: 23616031
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
Lancet. 2019 May 18;393(10185):2030-2031
pubmed: 31106741
Child Adolesc Ment Health. 2016 May;21(2):115-123
pubmed: 32680371
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
Psychol Assess. 2012 Dec;24(4):833-45
pubmed: 22329531

Auteurs

Mick Cooper (M)

Department of Psychology, University of Roehampton, London, UK. Electronic address: mick.cooper@roehampton.ac.uk.

Megan R Stafford (MR)

Department of Psychology, University of Roehampton, London, UK.

David Saxon (D)

Department of Psychology, University of Sheffield, Sheffield, UK.

Jennifer Beecham (J)

Personal Social Services Research Unit, University of Kent, Canterbury, UK; Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.

Eva-Maria Bonin (EM)

Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.

Michael Barkham (M)

Department of Psychology, University of Sheffield, Sheffield, UK.

Peter Bower (P)

National Institute for Health Research School for Primary Care Research, Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK.

Charlie Duncan (C)

British Association for Counselling and Psychotherapy, St John's Business Park, Lutterworth, UK.

Peter Pearce (P)

Metanoia Institute, London, UK.

Tiffany Rameswari (T)

Department of Psychology, University of Roehampton, London, UK.

Gemma Ryan (G)

British Association for Counselling and Psychotherapy, St John's Business Park, Lutterworth, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH